Picture of Eagle Pharmaceuticals logo

EGRX — Eagle Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Eagle Pharmaceuticals Reports Third Quarter 2022 Results

Nov 7 (Reuters) - Eagle Pharmaceuticals Inc  EGRX.O :
    * EAGLE PHARMACEUTICALS REPORTS THIRD QUARTER 2022 RESULTS
    * TOTAL REVENUE FOR Q3 2022 WAS $65.9 MILLION
    * QTRLY NET LOSS $0.27
    * QTRLY ADJUSTED EPS $1.12

Source text for Eikon:  ID:nGNXvxWBm 
Further company coverage:  EGRX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eagle Pharmaceuticals

See all news